C-Lab Ltd

As of December 31, 2016, C-Lab Ltd has 8.48M shares outstanding.

As of December 31, 2016, C-Lab Ltd maintains a current ratio of 0.90, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended December 31, 2016, C-Lab Ltd posted a return on equity (ROE) of 8.75, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 6.12, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.51, useful for judging operating efficiency across full business cycles. Inventory turnover of 2.01 indicates how many times C-Lab Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

These figures cover the twelve months ended December 31, 2016. That works out to an effective tax rate of 6.28, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

As of the close on February 10, 2026, C-Lab Ltd's stock has declined approximately 5.66% over the past 52 weeks. The 50-day moving average sits at 1,036.30, while the 200-day moving average is 1,036.44.

Over the twelve months ended December 31, 2016, C-Lab Ltd posted a gross margin of 32.49, reflecting its pricing power and cost economics. The operating margin of 8.04 and net profit margin of 6.39 provide insight into operational efficiency.

As of December 31, 2016, C-Lab Ltd has an Altman Z-Score of 2.61, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.